Skip to main content

Peer Review reports

From: Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis

Original Submission
6 Jan 2024 Submitted Original manuscript
18 Apr 2024 Reviewed Reviewer Report
26 Apr 2024 Reviewed Reviewer Report - Santosh Kale
15 May 2024 Author responded Author comments - Jiangfeng Wang
Resubmission - Version 2
15 May 2024 Submitted Manuscript version 2
Publishing
23 May 2024 Editorially accepted
29 May 2024 Article published 10.1186/s12885-024-12423-2

You can find further information about peer review here.

Back to article page